Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (400)	1/25/1999 5:40:00 PM
From: scaram(o)uche	Respond to of 4974

Lampert, Microcide, filed 1/22....... (9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,625,000 ------------------------------------------------------------------------------- (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / ------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row (9) 14.8% and, from a 1/14 filing........ ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Since November 14, 1998, Partners, in its capacity as general partner of BVF, has purchased on behalf of such limited partnership an aggregate number of 83,100 shares of the Stock for an aggregate consideration of $343,341.50, utilizing funds provided by BVF from its working capital pursuant to the terms of its limited partnership agreement with Partners. In addition, Partners, in its capacity as investment manager with respect to certain managed accounts, has purchased on behalf of such managed accounts an aggregate number of 58,500 shares of the Stock for an aggregate consideration of $246,926.25, utilizing funds under management by Partners pursuant to investment manager agreements between Partners and such managed accounts. Item 5 is hereby amended to read in its entirety as follows: ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) BVF beneficially owns 757,200 shares of the Stock, Partners beneficially owns 1,625,000 shares of the Stock, and BVF Inc. beneficially owns 1,625,000 shares of the Stock, approximately 6.9%, 14.8% and 14.8%, respectively, of the aggregate number of shares outstanding as of October 30, 1998 (as reported in Microcide's most recent quarterly statement on Form 10-Q).